Suppr超能文献

术前中性粒细胞与淋巴细胞比值升高对接受根治性手术的结直肠癌患者的预后意义:一项荟萃分析。

Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis.

作者信息

Li Hongcai, Zhao Yan, Zheng Fengying

机构信息

Department of Medicine, Binzhou Polytechnic College, Binzhou 256600, Shandong, China.

出版信息

Medicine (Baltimore). 2019 Jan;98(3):e14126. doi: 10.1097/MD.0000000000014126.

Abstract

BACKGROUND

Preoperative neutrophil-to-lymphocyte ratio (NLR) has been suggested as a useful predictive factor for prognosis in patients with various cancers. However, the prognostic value of NLR in patients with colorectal cancer (CRC) remains controversial. Therefore, the goal of this study was to perform a meta-analysis to evaluate the prognostic value of NLR in patients with CRC undergoing curative surgery.

METHODS

PubMed, EMBASE and Cochrane Library databases were searched to screen the relevant studies. Pooled hazard ratio (HR) with 95% confidence interval (CI) was used to assess the associations of preoperative NLR and overall survival (OS), disease-free survival (DFS), recurrence free survival (RFS) and disease specific survival (DSS) by STATA 13.0 software.

RESULTS

Sixteen studies involving 5897 patients were included in our meta-analysis. Our pooled results demonstrated that high NLR was associated with poor OS (HR: 1.66, 95%CI: 1.36-2.02, P < .001), DFS (HR = 1.54, 95%CI: 1.18-2.02, P = .002), RFS (HR = 2.31, 95%CI: 1.68-3.17, P < .001) and DSS (HR = 2.27; 95% CI: 1.75-2.96, P < .001). When the patients were stratified according to country, sample size, NLR cut-off, follow up and postoperative chemotherapy, high NLR was still significantly correlated with OS. The limitation was that the majority of enrolled studies were retrospective.

CONCLUSION

Preoperative NLR may be an effective predictive biomarker for prognosis in patients with CRC. Detection of NLR may be beneficial to identify the high-risk patients who need other antitumor therapies in addition to surgery.

摘要

背景

术前中性粒细胞与淋巴细胞比值(NLR)已被认为是各种癌症患者预后的一个有用预测因素。然而,NLR在结直肠癌(CRC)患者中的预后价值仍存在争议。因此,本研究的目的是进行一项荟萃分析,以评估NLR在接受根治性手术的CRC患者中的预后价值。

方法

检索PubMed、EMBASE和Cochrane图书馆数据库以筛选相关研究。使用STATA 13.0软件,采用合并风险比(HR)及95%置信区间(CI)来评估术前NLR与总生存期(OS)、无病生存期(DFS)、无复发生存期(RFS)和疾病特异性生存期(DSS)之间的关联。

结果

我们的荟萃分析纳入了16项研究,共5897例患者。我们的合并结果表明,高NLR与较差的OS(HR:1.66,95%CI:1.36 - 2.02,P <.001)、DFS(HR = 1.54,95%CI:1.18 - 2.02,P =.002)、RFS(HR = 2.31,95%CI:1.68 - 3.17,P <.001)和DSS(HR = 2.27;95%CI:1.75 - 2.96,P <.001)相关。当根据国家、样本量、NLR临界值、随访和术后化疗对患者进行分层时,高NLR仍与OS显著相关。局限性在于纳入的大多数研究为回顾性研究。

结论

术前NLR可能是CRC患者预后的一个有效预测生物标志物。检测NLR可能有助于识别除手术外还需要其他抗肿瘤治疗的高危患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665c/6370071/e0f217dacb2d/medi-98-e14126-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验